Decker MW[au] - Search Results

Year	Number of Results
1985	2
1987	2
1988	1
1989	2
1990	4
1991	1
1992	2
1993	4
1994	8
1995	10
1996	4
1997	6
1998	12
1999	3
2000	4
2001	1
2002	2
2003	3
2004	10
2005	12
2006	13
2007	6
2008	3
2009	5
2010	7
2011	3
2012	1
2013	1
2014	4
2015	2
2022	0

1

Cognition Models and Drug Discovery.

Decker MW. Decker MW. In: Levin ED, Buccafusco JJ, editors. Animal Models of Cognitive Impairment. Boca Raton (FL): CRC Press/Taylor & Francis; 2006. Chapter 16. In: Levin ED, Buccafusco JJ, editors. Animal Models of Cognitive Impairment. Boca Raton (FL): CRC Press/Taylor & Francis; 2006. Chapter 16. PMID: 21204368 Free Books & Documents. Review.

2

Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.

Wilens TE, Decker MW. Wilens TE, et al. Among authors: decker mw. Biochem Pharmacol. 2007 Oct 15;74(8):1212-23. doi: 10.1016/j.bcp.2007.07.002. Epub 2007 Jul 7. Biochem Pharmacol. 2007. PMID: 17689498 Free PMC article. Review.

3

Nicotinic acetylcholine receptor agonists: a potential new class of analgesics.

Decker MW, Rueter LE, Bitner RS. Decker MW, et al. Curr Top Med Chem. 2004;4(3):369-84. doi: 10.2174/1568026043451447. Curr Top Med Chem. 2004. PMID: 14754452 Review.

4

The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.

Decker MW, Curzon P, Holladay MW, Nikkel AL, Bitner RS, Bannon AW, Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Williams M, Arneric SP. Decker MW, et al. J Physiol Paris. 1998 Jun-Aug;92(3-4):221-4. doi: 10.1016/s0928-4257(98)80014-4. J Physiol Paris. 1998. PMID: 9789812 Review.

5

Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career.

Terry AV Jr, Decker MW. Terry AV Jr, et al. Among authors: decker mw. Biochem Pharmacol. 2011 Oct 15;82(8):883-90. doi: 10.1016/j.bcp.2011.06.010. Epub 2011 Jun 12. Biochem Pharmacol. 2011. PMID: 21684265 Free PMC article. Review.

6

The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory.

Decker MW, McGaugh JL. Decker MW, et al. Synapse. 1991 Feb;7(2):151-68. doi: 10.1002/syn.890070209. Synapse. 1991. PMID: 1672782 Review.

7

The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system.

Decker MW. Decker MW. Brain Res. 1987 Nov;434(4):423-38. doi: 10.1016/0165-0173(87)90007-5. Brain Res. 1987. PMID: 3319050 Review.

8

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control.

Decker MW, Meyer MD, Sullivan JP. Decker MW, et al. Expert Opin Investig Drugs. 2001 Oct;10(10):1819-30. doi: 10.1517/13543784.10.10.1819. Expert Opin Investig Drugs. 2001. PMID: 11772288 Review.

9

Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics.

Decker MW, Meyer MD. Decker MW, et al. Biochem Pharmacol. 1999 Sep 15;58(6):917-23. doi: 10.1016/s0006-2952(99)00122-7. Biochem Pharmacol. 1999. PMID: 10509744 Review.

10

Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics.

Daly JW, Garraffo HM, Spande TF, Decker MW, Sullivan JP, Williams M. Daly JW, et al. Among authors: decker mw. Nat Prod Rep. 2000 Apr;17(2):131-5. doi: 10.1039/a900728h. Nat Prod Rep. 2000. PMID: 10821107 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results